Published July 1991 | Version v1
Journal article

Solubilization of a guanine nucleotide-sensitive form of the P2Y-purinergic receptor

  • 1. Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill (USA)

Description

P2Y-Purinergic receptors were solubilized from turkey erythrocyte plasma membranes with the nonionic detergent digitonin. Adenosine 5'-O-(2-[35S]thiodiphosphate) ([35S]ADP β S) labeled a single population of soluble high affinity sites (Kd = 12.9 nM; Bmax = 4.5 pmol/mg of protein) in an equilibrium binding assay; adenine nucleotide analogs competitively inhibited [35S]ADP β S binding with a rank order of potency consistent with that for P2Y-purinergic receptors. Radioligand binding to solubilized P2Y-purinergic receptors was noncompetitively inhibited by guanine nucleotides with a rank order of potency that was in agreement with the potency order observed for guanine nucleotide-mediated inhibition of [35S]ADP β S binding in purified turkey erythrocyte plasma membranes. The rate constant for dissociation of [35S]ADP beta S from solubilized receptors was increased 2.3-fold by guanosine 5'-O-(3-thiotriphosphate) (GTP γ S). Plasma membrane P2Y-purinergic receptors were labeled with [35S]ADP β S or covalently labeled with the photoaffinity probe 3'-O-(4-benzoyl)benzoyl adenosine 5'-[α-32P]triphosphate ([α-32P]BzATP) before solubilization and gel filtration chromatography on Superose 12. [35S]ADP β S- or [alpha-32P]BzATP-labeled species eluted as a single peak of radioactivity of apparent Mr greater than or equal to 300,000. Incubation of the Mr greater than or equal to 300,000 protein species with GTP γ S before rechromatography resulted in loss of labeling of proteins by [35S]ADP β S and a shift in apparent size of the covalently [α-32P]BzATP-labeled species to a single peak of radioactivity of approximate Mr 70,000. These results suggest that a P2Y-purinergic receptor-guanine nucleotide regulatory protein complex is stable to membrane solubilization with digitonin, even in the absence of prebound agonist

Additional details

Publishing Information

Journal Title
Molecular Pharmacology
Journal Volume
40
Journal Issue
1
Series
Mol. Pharmacol.
Journal Page Range
85-92
ISSN
0026-895X
CODEN
MOPMA